Creating engineered tissue to help replace lost neurons in the brain
Tissue Engineered Rostral Migratory Stream for Directed Neuronal Replacement
This study is exploring a new way to help the brain heal and grow new nerve cells after a traumatic brain injury, using special tissue that encourages the right connections to form, which could help patients recover better and regain their abilities.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11060024 on NIH RePORTER |
What this research studies
This research focuses on developing a new method to enhance the brain's ability to regenerate neurons after traumatic brain injury (TBI). By creating a bioengineered tissue that mimics the natural pathways in the brain, the team aims to guide new neurons to areas where they are needed most. The approach involves using advanced techniques to assemble astrocytes into structures that can support neuron migration and integration into existing brain circuits. Patients may benefit from this innovative strategy, which seeks to improve recovery and functionality after brain injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have experienced traumatic brain injuries.
Not a fit: Patients with chronic neurological conditions unrelated to traumatic brain injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve recovery outcomes for patients with traumatic brain injuries.
How similar studies have performed: Previous studies have shown promise in using engineered tissues for neuronal replacement, but this specific approach is novel and untested in humans.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Cullen, Daniel Kacy — University of Pennsylvania
- Study coordinator: Cullen, Daniel Kacy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.